These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26303011)

  • 1. PA401, a novel CXCL8-based biologic therapeutic with increased glycosaminoglycan binding, reduces bronchoalveolar lavage neutrophils and systemic inflammatory markers in a murine model of LPS-induced lung inflammation.
    Adage T; Del Bene F; Fiorentini F; Doornbos RP; Zankl C; Bartley MR; Kungl AJ
    Cytokine; 2015 Dec; 76(2):433-441. PubMed ID: 26303011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis.
    McElvaney OJ; O'Reilly N; White M; Lacey N; Pohl K; Gerlza T; Bergin DA; Kerr H; McCarthy C; O'Brien ME; Adage T; Kungl AJ; Reeves EP; McElvaney NG
    Mol Immunol; 2015 Feb; 63(2):550-8. PubMed ID: 25453468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting glycosaminoglycans in the lung by an engineered CXCL8 as a novel therapeutic approach to lung inflammation.
    Adage T; Konya V; Weber C; Strutzmann E; Fuchs T; Zankl C; Gerlza T; Jeremic D; Heinemann A; Kungl AJ
    Eur J Pharmacol; 2015 Feb; 748():83-92. PubMed ID: 25554213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo.
    Gschwandtner M; Strutzmann E; Teixeira MM; Anders HJ; Diedrichs-Möhring M; Gerlza T; Wildner G; Russo RC; Adage T; Kungl AJ
    Cytokine; 2017 Mar; 91():65-73. PubMed ID: 28011398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylation of a glycosaminoglycan-binding, dominant-negative CXCL8 mutant retains bioactivity in vitro and in vivo.
    Gerlza T; Trojacher C; Jeremic D; Krieger E; Adage T; Kungl A
    Cytokine; 2020 Mar; 127():154942. PubMed ID: 31794956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.
    Tanino Y; Coombe DR; Gill SE; Kett WC; Kajikawa O; Proudfoot AE; Wells TN; Parks WC; Wight TN; Martin TR; Frevert CW
    J Immunol; 2010 Mar; 184(5):2677-85. PubMed ID: 20124102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porcine CXCR1/2 antagonist CXCL8
    Wang X; Li Y; Li L; Jiao Z; Liu X; Cheng G; Gu C; Hu X; Zhang W
    Sci Rep; 2020 Jan; 10(1):1210. PubMed ID: 31988368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice.
    Xie YC; Dong XW; Wu XM; Yan XF; Xie QM
    Int Immunopharmacol; 2009 Feb; 9(2):194-200. PubMed ID: 19071231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF.
    Puljic R; Benediktus E; Plater-Zyberk C; Baeuerle PA; Szelenyi S; Brune K; Pahl A
    Eur J Pharmacol; 2007 Feb; 557(2-3):230-5. PubMed ID: 17174948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells.
    Derler R; Gesslbauer B; Weber C; Strutzmann E; Miller I; Kungl A
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effect of pre-elafin in lipopolysaccharide-induced acute lung inflammation.
    Vachon E; Bourbonnais Y; Bingle CD; Rowe SJ; Janelle MF; Tremblay GM
    Biol Chem; 2002; 383(7-8):1249-56. PubMed ID: 12437112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo.
    Falsone A; Wabitsch V; Geretti E; Potzinger H; Gerlza T; Robinson J; Adage T; Teixeira MM; Kungl AJ
    Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23919527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid.
    Freedman SD; Weinstein D; Blanco PG; Martinez-Clark P; Urman S; Zaman M; Morrow JD; Alvarez JG
    J Appl Physiol (1985); 2002 May; 92(5):2169-76. PubMed ID: 11960971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobic exercise inhibits acute lung injury: from mouse to human evidence Exercise reduced lung injury markers in mouse and in cells.
    Rigonato-Oliveira NC; Mackenzie B; Bachi ALL; Oliveira-Junior MC; Santos-Dias A; Brandao-Rangel MAR; Delle H; Costa-Guimaraes T; Damaceno-Rodrigues NR; Dulley NR; Benetti MA; Malfitano C; de Angelis C; Albertini R; Oliveira APL; Abbasi A; Northoff H; Vieira RP
    Exerc Immunol Rev; 2018; 24():36-44. PubMed ID: 29461970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation.
    Martínez-Burgo B; Cobb SL; Pohl E; Kashanin D; Paul T; Kirby JA; Sheerin NS; Ali S
    Immunology; 2019 Jun; 157(2):173-184. PubMed ID: 31013364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated pulmonary vascular neutrophils as early mediators of endotoxin-induced lung inflammation.
    Williams JH; Patel SK; Hatakeyama D; Arian R; Guo K; Hickey TJ; Liao SY; Ulich TR
    Am J Respir Cell Mol Biol; 1993 Feb; 8(2):134-44. PubMed ID: 8381291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level laser therapy reduces acute lung inflammation in a model of pulmonary and extrapulmonary LPS-induced ARDS.
    Oliveira MC; Greiffo FR; Rigonato-Oliveira NC; Custódio RW; Silva VR; Damaceno-Rodrigues NR; Almeida FM; Albertini R; Lopes-Martins RÁ; de Oliveira LV; de Carvalho Pde T; Ligeiro de Oliveira AP; Leal EC; Vieira RP
    J Photochem Photobiol B; 2014 May; 134():57-63. PubMed ID: 24792475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
    Joseph PRB; Sawant KV; Rajarathnam K
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
    Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
    Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.
    Vanheule V; Janssens R; Boff D; Kitic N; Berghmans N; Ronsse I; Kungl AJ; Amaral FA; Teixeira MM; Van Damme J; Proost P; Mortier A
    J Biol Chem; 2015 Aug; 290(35):21292-304. PubMed ID: 26183778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.